Author:
Cultrone Daniele,Zammit Nathan W.,Self Eleanor,Postert Benno,Han Jeremy Z. R.,Bailey Jacqueline,Warren Joanna,Croucher David R.,Kikuchi Kazu,Bogdanovic Ozren,Chtanova Tatyana,Hesselson Daniel,Grey Shane T.
Abstract
AbstractGermline loss-of-function variation inTNFAIP3, encoding A20, has been implicated in a wide variety of autoinflammatory and autoimmune conditions, with acquired somatic missense mutations linked to cancer progression. Furthermore, human sequence data reveals that the A20 locus contains ~ 400 non-synonymous coding variants, which are largely uncharacterised. The growing number of A20 coding variants with unknown function, but potential clinical impact, poses a challenge to traditional mouse-based approaches. Here we report the development of a novel functional genomics approach that utilizes a new A20-deficient zebrafish (Danio rerio) model to investigate the impact ofTNFAIP3genetic variants in vivo. A20-deficient zebrafish are hyper-responsive to microbial immune activation and exhibit spontaneous early lethality. Ectopic addition of human A20 rescued A20-null zebrafish from lethality, while missense mutations at two conserved A20 residues, S381A and C243Y, reversed this protective effect. Ser381 represents a phosphorylation site important for enhancing A20 activity that is abrogated by its mutation to alanine, or by a causal C243Y mutation that triggers human autoimmune disease. These data reveal an evolutionarily conserved role forTNFAIP3in limiting inflammation in the vertebrate linage and show how this function is controlled by phosphorylation. They also demonstrate how a zebrafish functional genomics pipeline can be utilized to investigate the in vivo significance of medically relevant humanTNFAIP3gene variants.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
National Health and Medical Research Council
Juvenile Diabetes Research Foundation United States of America
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Lee, E. G. Failure to regulate TNF-induced NF-kappa B and cell death responses in A20-deficient mice. Science 289, 2350–2354. https://doi.org/10.1126/science.289.5488.2350 (2000).
2. Cooper, J. T. et al. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism. J. Biol. Chem. 271, 18068–18073 (1996).
3. Grey, S. T., Arvelo, M. B., Hasenkamp, W., Bach, F. H. & Ferran, C. A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets. J. Exp. Med. 190, 1135–1146 (1999).
4. Song, H. Y., Rothe, M. & Goeddel, D. V. The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activation. Proc. Natl. Acad. Sci. U. S. A. 93, 6721–6725 (1996).
5. Jaattela, M., Mouritzen, H., Elling, F. & Bastholm, L. A20 zinc finger protein inhibits TNF and IL-1 signaling. J. Immunol. 156, 1166–1173 (1996).
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献